At 1.9% CAGR, Middle East & Africa Positive Airway Pressure (PAP) Devices Market is Projected to be Worth US$ 292.08 Million by 2031, Says Business Market Insights

According to The Insight Partner research, the Middle East & Africa positive airway pressure (PAP) devices market was valued at US$ 251.81 million in 2023 and is expected to reach US$ 292.08 million by 2031, registering a CAGR of 1.9% from 2023 to 2031. Technological advancement and increasing demand for positive airway pressure devices are among the critical factors attributed to the Middle East & Africa positive airway pressure (PAP) devices market expansion.

Historically, sleep apnea was managed using CPAP machines, lifestyle modifications, and surgical procedures. However, new developments in sleep apnea treatment technology are transforming diagnosis, tracking, and treatment. The management of sleep apnea has become more convenient, practical, and comfortable due to the development of cutting-edge diagnostic tools, inventive treatment devices, and remote monitoring capabilities. Technological developments are likely to improve the lives of people with sleep apnea. For example, the SleepStyle CPAP is renowned for its integrated humidifier and user-friendly interface. This has a smartphone app for compliance and monitoring, as well as Bluetooth connectivity. The small and lightweight Somnetics Transcend 3 Mini CPAP features cutting-edge noise-cancelling technology. It has Bluetooth connectivity, intelligent pressure adjustments, and is travel friendly. In order to anticipate apnea episodes during sleep, NovaResp Technologies Inc. is creating an artificial intelligence (AI)-enabled CPAP algorithm to work with any CPAP, including the device that the company is currently developing.

These innovations are expanding the market and giving businesses a competitive edge when managing respiratory conditions such as sleep apnea and having high adoption rates.

On the contrary, product recall hampers the growth of Middle East & Africa positive airway pressure (PAP) devices market.

Based on product type, the Middle East & Africa positive airway pressure (PAP) devices market is segmented into automatic positive airway pressure (APAP) devices, continuous positive airway pressure (CPAP) devices, and bilevel positive airway pressure (BiPAP) devices. The continuous positive airway pressure (CPAP) devices segment held 66.4% share of the Middle East & Africa positive airway pressure (PAP) devices market in 2023, amassing US$ 167.11 million. It is projected to garner US$ 199.50 million by 2031 to expand at 2.2% CAGR during 2023–2031.

Based on process or phase, the Middle East & Africa positive airway pressure (PAP) devices market is segmented into chronic obstructive pulmonary disease (COPD), obstructive sleep apnea, and respiratory distress. The obstructive sleep apnea segment held 74.2% share of the Middle East & Africa positive airway pressure (PAP) devices market in 2023, amassing US$ 186.74 million. It is projected to garner US$ 221.28 million by 2031 to expand at 2.1% CAGR during 2023–2031.

Based on end user, the Middle East & Africa positive airway pressure (PAP) devices market is segmented into hospitals, ambulatory surgical centers, home care, and rehabilitation centers. The hospitals segment held 56.6% share of the Middle East & Africa positive airway pressure (PAP) devices market in 2023, amassing US$ 142.46 million. It is projected to garner US$ 172.45 million by 2031 to expand at 2.4% CAGR during 2023–2031.

Based on country, the Middle East & Africa positive airway pressure (PAP) devices market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East and Africa. Saudi Arabia held 35.6% share of Middle East & Africa positive airway pressure (PAP) devices market in 2023, amassing US$ 89.72 million. It is projected to garner US$ 107.57 million by 2031 to expand at 2.3% CAGR during 2023–2031.

Key players operating in the positive airway pressure (PAP) devices market are ICU Medical Inc; React Health (Formerly 3B Medical, Inc); Fisher & Paykel Healthcare Corp Ltd; BPL Medical Technologies Pvt Ltd; Koninklijke Philips NV; Dragerwerk AG & Co KGaA; ResMed Inc; Vyaire Medical Inc; Wellell Inc; Armstrong Medical Ltd; Löwenstein Medical UK Ltd.; BMC Medical Co Ltd; and Narang Medical Limited., among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com